Description: This session from the 1992 Valuation Actuary Symposium reviews the appointed actuary concept, the actuarial opinion and asset adequacy analysis as they apply to health insurance and expresses the views of one regulator on the subject and one actuary in terms of the actuarial standards of practice.

Description: This literature guide provides a basic grounding for product development actuaries.

Description: A discussion of the future of the Brazilian Health Market with a focus on the legislation which passed in June 1998 to regulate the private health insurance industry

Description: On Dec. 29, 1973 President Nixon signed into law the Health Maintenance Organization Act of 1973, which authorizes $375 million to be used by the DHEW to stimulate the establishment and development of HMO's over the next five years. This article describes the status of the regulations and the development of additional HMO's.

Description: This discussion about group Life and group Accident and Health insurance covered over insurance, medical catastrophe coverage, conversion privilege, and the regulatory environment. From TRANSACTIONS OF SOCIETY OF ACTUARIES, 1953 VOL. 5 NO. 11.

Description: This panel discussion session examines the marketing and pricing considerations of group insurance in the 1980's.

Description: Discussion of the following topics pertaining to disability income and other health insurance: 1. What portions of the loss of income and of the expenses incurred are properly insurable? 2. What special problems are encountered in providing suitable coverage for the following: a Employees and dependents eligible under Group plans b Individuals employed or not employed and their dependents ineligible under Group plans c Aged persons. 3. Methods for companies to meet the problems of overinsurance arising from duplication of coverage or from other causes?

Description: This 1980 session is about effect of government actions and consumerism on product design and pricing. Areas addressed: 1. What have been the most important regulatory and consumerist actions in the past decade as related to products, their marketing and the overall operation of a life insurance company? 2. What will be the most important actions in these arenas in the next decade? 3. What specific impact have these regulatory and consumer actions had on companies in the past decade and will they have in the coming decade? 4. What true value has accrued to consumers and the public because of these actions, and what impact will they have in the next decade? 5. Is there an acceptable relationship between the value of these benefits and the cost to the companies of providing them?

Description: Presented at October 1996 Annual Meeting. This session presents and discusses the NAIC's model bill for risk-based capital as it relates to health insurance.

Description: Discussion of anticipated marketing and pricing considerations of Group Insurance in the 1980's including: a. Regulatory environment including National Health Insurance b. Economic and growth potential c. Competition including Health Maintenance Organizations d. Technology e. Evolving role of employee benefits f. Products g. Pricing considerations h. Marketing approaches Also, discussion of the 1960's and the 1970's a. Major influences b. Benefit changes c. Alternate funding approaches 2. The 1980's environment a.